Drug Dealing and Brokering Lawyer | What Determines Your Sentence, and How to Challenge It

Drug Dealing and Brokering | How the Law Classifies Dealing and Brokering

The Act on Control of Narcotics, etc. (마약류관리에관한법률) does not treat all 'trafficking' the same way. The charge you face depends on the type of narcotic, the quantity, and whether your conduct is classified as manufacture, import, sale, or brokering.

Drug Dealing and Brokering | Why Quantity Changes Everything

In drug dealing cases, the single most consequential fact is often not whether you sold drugs, but how much the prosecution attributes to you. Small differences in quantity calculation can move a case from a suspended sentence to a mandatory multi-year term.

How Prosecutors Calculate 'Quantity'

Investigators frequently aggregate every transaction they can trace to a suspect over months, including transactions proven only through co-defendant statements or phone records, not just the amount seized at arrest. Whether each alleged transaction is separately provable, and whether aggregation across time is legally appropriate, is a key point to examine with defense counsel.

Large-Quantity Thresholds and Their Practical Effect

Once quantity crosses certain statutory or guideline thresholds, the applicable minimum sentence jumps sharply and the case may be treated as an aggravated trafficking case rather than an ordinary sale (마약류관리에관한법률 제58조, 제59조). Challenging the purity, weight measurement, or the number of separate acts counted can meaningfully affect which threshold applies.

Prior Record and Repeat Offense Enhancement

A prior narcotics conviction, even an old or minor one, can trigger repeat-offender enhancement provisions that raise both the statutory minimum and the range courts typically apply in practice. Distinguishing a prior simple-use conviction from a prior sale conviction matters for how much enhancement actually applies.

Drug Dealing and Brokering | Seller, Broker, or Bystander — Why the Label Matters

Korean narcotics law and sentencing practice draw real distinctions between the person who profited from a sale, the person who merely introduced a buyer to a seller, and someone who was present or assisted without direct financial gain. These distinctions are often contested at trial.

Distinguishing 'Sale' from 'Brokering'

A seller is someone who has possession or control of the drug and transfers it in exchange for payment; a broker merely arranges or facilitates the transaction between others (마약류관리에관한법률 제59조). Both are punished under the same article, but courts have historically weighed a broker's lack of direct profit and lack of possession as a mitigating factor in sentencing within the applicable range.

'Simple Use' vs. 'Sale' When Drugs Change Hands Without Payment

Sharing drugs with a friend without payment, or purchasing on someone else's behalf purely for shared personal use, can sometimes be argued as joint possession or use rather than sale, which carries a materially different sentencing range. Whether money or any benefit-in-kind changed hands is central to this distinction, and it is frequently the first fact investigators focus on.

Entrapment and Controlled Buy Issues

Some cases originate from undercover purchases or informant-arranged transactions. Whether the investigative method crossed from legitimate undercover investigation into impermissible inducement (entrapment) can, in limited circumstances, affect the admissibility of evidence or the characterization of the defendant's role.

Drug Dealing and Brokering | Disputing Co-Conspirator Liability

Drug distribution networks are usually investigated and prosecuted as a group, and prosecutors often seek to hold every participant liable for the full scope of the network's activity, not just each person's individual acts. This is one of the most fertile grounds for defense in multi-defendant narcotics cases.

Co-Principal vs. Aiding and Abetting

Under general criminal law principles, being charged as a co-principal (공동정범) requires proof of a shared intent and functional role in the crime, not merely awareness that a crime was occurring nearby (형법 제30조). A person who, for example, only lent a phone or a room without knowledge of the specific transaction may have grounds to argue for aiding and abetting liability (형법 제32조) or no liability at all, which carries a lighter sentencing range.

Attributing a Co-Defendant's Total Sales to You

When one member of a network is proven to have sold a large cumulative quantity, prosecutors sometimes attempt to attribute that entire quantity to every co-defendant on a conspiracy theory. Whether the evidence actually shows you shared in the profits or decision-making for the full scope of the operation, rather than only your own discrete acts, is a central question that can significantly change your exposure.

Reliability of Co-Defendant Statements

Many multi-defendant narcotics cases rely heavily on statements co-defendants gave investigators, often made under the incentive of receiving more lenient treatment for cooperating. Cross-examining the consistency, timing, and motive behind such statements is frequently a key part of trial strategy.

Drug Dealing and Brokering | From Arrest or Summons to Resolution

Drug Dealing and Brokering | How Fees Are Set in Drug Dealing Cases

※ Costs vary depending on case complexity and specific circumstances; exact fees will be provided during consultation. No specific outcome is guaranteed.

Drug Dealing and Brokering | Self-Check Before You Speak to Investigators

Frequently Asked Questions

Official References

• Korea Law Information Center — https://www.law.go.kr
• Easy-to-Find Everyday Legal Information — https://easylaw.go.kr
• Korea Legal Aid Corporation — https://www.klac.or.kr